Bilberry Pharmaceuticals

Provision of quality ethical drugs and pharmaceuticals with a focus on assurance systems.

About Bilberry Pharmaceuticals

The company has 21 employees. Bilberry Pharmaceuticals offers products and services including Ethical Drugs and Quality Assurance Services.

  • Employees 21
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Legal Name Bilberry Pharmaceuticals Pvt Limited
  • Date of Incorporation 08 Nov, 2016
  • Jurisdiction Indore, Madhya Pradesh, India
Key Metrics
  • Annual Revenue
    ₹6.62 Cr

    FY 2024 · +67% YoY

  • Net Profit
    ₹3.3 Lakh

    FY 2024 · 1% margin

  • EBITDA
    ₹23.9 Lakh

    FY 2024 · 4% margin

  • Employee Count
    21

Products & Services of Bilberry Pharmaceuticals

Bilberry Pharmaceuticals offers a comprehensive portfolio of products and services, including Ethical Drugs and Quality Assurance Services.

Ethical Drugs
Pharmaceutical Products

Ethical drugs in various finished dosage forms are manufactured and supplied for medical use.

Quality Assurance Services
Quality Management

Quality assurance and control systems are implemented to monitor and ensure product standards.

Board of directors of Bilberry Pharmaceuticals Private Limited (Bilberry Pharmaceuticals)

Bilberry Pharmaceuticals Private Limited is the primary company behind Bilberry Pharmaceuticals. The board of Bilberry Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Devendra Kumar Pathak, appointed in 2016. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Devendra Kumar Pathak
DIN 07635109
Director08 Nov 20169 yrs 11 moBilberry Pharmaceuticals Private Limited
Roshni Pathak
DIN 07674550
Director17 Nov 20169 yrs 10 moBilberry Pharmaceuticals Private Limited

Financials of Bilberry Pharmaceuticals

Figures of Bilberry Pharmaceuticals Private Limited, the primary company behind Bilberry Pharmaceuticals, for FY 2024. Revenue was ₹6.62 Cr (+67% year on year). Net profit was ₹3.3 Lakh (1% margin). EBITDA was ₹23.9 Lakh (4% margin). Revenue has grown at a compounded annual rate of +58% over three years and +46% over five years.

  • ₹6.62 CrRevenue · FY 2024 · +67% YoY
  • ₹3.3 LakhNet profit · 1% margin
  • ₹23.9 LakhEBITDA · 4% margin
  • ₹4 LakhPaid-up capital
  • 21Employees (provident fund records)
  • +58%Revenue CAGR, 3 years
  • +46%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Bilberry Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Bilberry Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Bilberry Pharmaceuticals

10 companies that operate in the same segment as Bilberry Pharmaceuticals (Hospitals & Clinical Care), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Maternity, childcare, and fertility services are delivered via hospital chains.
2007Bengaluru, Karnataka, IndiaUSD 204.87 MUSD 140.46 M4,459
Chain of oncology hospitals
1989Bengaluru, Karnataka, IndiaUSD 90.03 MUSD 270.51 M8,400
Chain of multi-super specialty healthcare hospitals
2004Gurugram, Haryana, IndiaUSD 104.7 MUSD 461.72 M12,240
Multispeciality secondary and tertiary care is provided by hospital chains.
1999Secunderabad, Telangana, IndiaUSD 62.46 MUSD 416.2 M6,490
Multispecialty hospitals are operated as a chain in India.
2001Delhi, Delhi, India–USD 889.96 M26,830
Multi-specialty hospitals and surgery centers are operated nationwide.
1968Nashville, Tennessee, United StatesUSD 97.27 MUSD 75.6 B316,000
Standalone veterinary clinics are operated for pet care services.
2017New York, New York, United StatesUSD 98.5 M––
Healthcare services, research, education, and community support are provided.
1942United States–––
Multispecialty hospitals are operated as a chain in India.
1991Bengaluru, Karnataka, IndiaUSD 645.32 MUSD 1.1 B–
Healthcare services are delivered through integrated hospital networks.
2002United States–––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Bilberry Pharmaceuticals

Bilberry Pharmaceuticals has 21 employees.

The primary company behind Bilberry Pharmaceuticals, Bilberry Pharmaceuticals Private Limited, reported revenue of β‚Ή6.62 Cr for FY 2024, up 67% year on year.

Bilberry Pharmaceuticals is known for its emphasis on quality in the pharmaceutical sector, where a wide range of ethical drugs in various finished dosage forms is offered at affordable prices. A robust Quality Assurance and Control System is maintained, with in-process controls monitored by quality assurance executives through internal audits, training, and validations. Diversity in products and perspectives is valued, and leading-edge science is advanced for health improvements. Trust is built through commitments to high standards of quality, excellence, and integrity, as the company operates from its base in Indore, India.

Bilberry Pharmaceuticals offers Ethical Drugs and Quality Assurance Services.

Bilberry Pharmaceuticals operates through Bilberry Pharmaceuticals Private Limited.

The legal entities of Bilberry Pharmaceuticals currently have 2 directors, including Devendra Kumar Pathak, Roshni Pathak.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available